New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and even performed worse than an older range of treatments called triptans, said ...
The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...
The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...
The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...
A migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it's usefulness.
The FDA demanded a pharma-giant to cease running advertisements featuring tennis legend Serena Williams, claiming the ...
A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...
US government watchdog, the Food and Drug Administration have issued official correspondence to drugmakers AbbVie, informing ...
Facing off against oral drugs such as AbbVie’s Ubrelvy, Tonix is seeking to raise awareness of potential benefits of nasal ...
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...
According to a letter released by the FDA, the advertisement makes false or misleading claims about the drug's efficacy in treating migraine pain. The agency added that the ad exaggerates the speed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback